Literature DB >> 18308687

Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study.

Eldrin F Lewis1, Eric J Velazquez, Scott D Solomon, Anne S Hellkamp, John J V McMurray, Jasmine Mathias, Jean-Lucien Rouleau, Aldo P Maggioni, Karl Swedberg, Lars Kober, Harvey White, Anthony J Dalby, Gary S Francis, Faiez Zannad, Robert M Califf, Marc A Pfeffer.   

Abstract

AIMS: We sought to assess the incidence of and prognostic factors for heart failure (HF) hospitalization among survivors of high-risk acute myocardial infarction (MI). METHODS AND
RESULTS: We assessed the risk of an initial hospitalization for HF in 11 040 stable MI patients (no major non-fatal cardiovascular events or deaths within 45 days of randomization) without a prior history of HF enrolled in the VALIANT trial. Multivariable models were developed to identify independent predictors of HF and HF or cardiovascular death. Of 11 040 stable post-MI patients, 1139 (10.3%) developed HF during the median 25-month follow-up at a rate of approximately 3.4% per year. Most patients, 824 (72.3%), did not have a symptomatic recurrent MI between randomization and the onset of HF. The most important predictors of HF were older age, antecedent diabetes, prior MI before index MI, and reduced renal function. HF markedly increased the risk of death [HR(hazard ratio) 8.22; 95% CI(confidence interval), 7.49-9.01].
CONCLUSION: HF post high risk-MI occurs in a time-dependent fashion and is usually not directly related to re-infarction. Patients who experience HF beyond the acute phase have increased mortality. Long-term survivors of high-risk MI should be followed closely and treated aggressively beyond the acute MI period.

Entities:  

Mesh:

Year:  2008        PMID: 18308687     DOI: 10.1093/eurheartj/ehn062

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  36 in total

1.  Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT).

Authors:  Harmony R Reynolds; Sandra A Forman; Jacqueline E Tamis-Holland; Philippe Gabriel Steg; Daniel B Mark; Camille A Pearte; Antonio C Carvalho; George Sopko; Li Liu; Gervasio A Lamas; Mariusz Kruk; Krystyna Loboz-Grudzien; Witold Ruzyllo; Judith S Hochman
Journal:  Am Heart J       Date:  2012-03       Impact factor: 4.749

2.  Quantitative myocardial blush score (QuBE) allows the prediction of heart failure development in long-term follow-up in patients with ST-segment elevation myocardial infarction: Proof of concept study.

Authors:  Andrzej Tomasik; Tomasz Młyńczak; Edyta Nowak; Katarzyna Pigoń; Artur Iwasieczko; Mariusz Opara; Ewa Nowalany-Kozielska
Journal:  Cardiol J       Date:  2017-11-13       Impact factor: 2.737

3.  Fragmented QRS in prediction of cardiac deaths and heart failure hospitalizations after myocardial infarction.

Authors:  Petri Korhonen; Terhi Husa; Teijo Konttila; Ilkka Tierala; Markku Mäkijärvi; Heikki Väänänen; Janne Ojanen; Aki Vehtari; Lauri Toivonen
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-04       Impact factor: 1.468

4.  Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model.

Authors:  Christopher M O'Connor; David J Whellan; Daniel Wojdyla; Eric Leifer; Robert M Clare; Stephen J Ellis; Lawrence J Fine; Jerome L Fleg; Faiez Zannad; Steven J Keteyian; Dalane W Kitzman; William E Kraus; David Rendall; Ileana L Piña; Lawton S Cooper; Mona Fiuzat; Kerry L Lee
Journal:  Circ Heart Fail       Date:  2011-11-23       Impact factor: 8.790

5.  Heart failure in post-MI patients with persistent IRA occlusion: prevalence, risk factors, and the long-term effect of PCI in the Occluded Artery Trial (OAT).

Authors:  Rahul R Jhaveri; Harmony R Reynolds; Stuart D Katz; Raban Jeger; Elzbieta Zinka; Sandra A Forman; Gervasio A Lamas; Judith S Hochman
Journal:  J Card Fail       Date:  2012-11       Impact factor: 5.712

6.  Mortality Associated With Heart Failure After Myocardial Infarction: A Contemporary Community Perspective.

Authors:  Yariv Gerber; Susan A Weston; Maurice Enriquez-Sarano; Cecilia Berardi; Alanna M Chamberlain; Sheila M Manemann; Ruoxiang Jiang; Shannon M Dunlay; Véronique L Roger
Journal:  Circ Heart Fail       Date:  2015-12-23       Impact factor: 8.790

Review 7.  Glycemic variability and glycemic control in the acutely ill cardiac patient.

Authors:  Jared Moore; Kathleen Dungan
Journal:  Heart Fail Clin       Date:  2012-08-09       Impact factor: 3.179

8.  Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Authors:  Pupalan Iyngkaran; Merlin Thomas; William Majoni; Nagesh S Anavekar; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-10-31       Impact factor: 2.041

Review 9.  Using proteomics to uncover extracellular matrix interactions during cardiac remodeling.

Authors:  Nicolle L Patterson; Rugmani Padmanabhan Iyer; Lisandra E de Castro Brás; Yaojun Li; Thomas G Andrews; Gregory J Aune; Richard A Lange; Merry L Lindsey
Journal:  Proteomics Clin Appl       Date:  2013-07-08       Impact factor: 3.494

10.  Cost-effectiveness of clopidogrel, prasugrel and ticagrelor for dual antiplatelet therapy after acute coronary syndrome: a decision-analytic model.

Authors:  Husam Abdel-Qadir; Idan Roifman; Harindra C Wijeysundera
Journal:  CMAJ Open       Date:  2015-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.